THE WORLD is on the cusp of a tussle between the need to urgently provide new treatments options for depression and the importance of thoroughly evaluating them before approval. With these words, Vidita Vaidya, a neuroscientist and professor at Mumbai’s Tata Institute of Fundamental Research, captured the essence of the global discourse on the use of controversial substances called psychedelics (a class of hallucinogens) in treating mental health problems. Vaidya was speaking at a science conference in Gurugram, Haryana, on February 24, 2024. “India, too, needs clinical trials to understand how these substances work and their potential risks,” she said.
Psychedelics are drugs that induce states of altered perception, behaviour, consciousness and thought, often with increased awareness of the senses. Though they belong to the same class psychotropic as other drugs for mental health problems, they seem to work better (see 'A class of its own'). Since about 30 per cent of the patients do not respond to current medications, as per a 2019 paper in BMC Psychiatry, psychedelics are increasingly being explored in some countries as alternate therapy for depression, anxiety, post-traumatic stress disorder (PTSD) and other mental health problems. As Vaidya notes, there is burning need for new treatments for depression, which is pushing governments to move quickly. So far, Australia, Canada, Denmark, Israel and a few states in the US (Oregon and Colorado) have allowed use of psychedelics for medicinal use.
A CLASS OF ITS OWN
What are psychedelic drugs and how are they different from other medicines that treat mental health problem
Esta historia es de la edición May 01, 2024 de Down To Earth.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición May 01, 2024 de Down To Earth.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
Trade On Emissions
EU's Carbon Border Adjustment Mechanism, a tariff on imports, is designed to protect European industries in the guise of climate action.
'The project will facilitate physical and cultural decimation of indigenous people'
The Great Nicobar Project has all the hallmarks of a disaster-seismic, ecological, human. Why did it get the go-ahead?
TASTE IT RED
Popularity of Karnataka's red jackfruit shows how biodiversity can be conserved by ensuring that communities benefit from it
MANY MYTHS OF CHIPKO
Misconceptions about the Chipko movement have overshadowed its true objectives.
The politics and economics of mpox
Africa's mpox epidemic stems from delayed responses, neglect of its health risks and the stark vaccine apartheid
Emerging risks
Even as the world gets set to eliminate substances threatening the ozone layer, climate change and space advancement pose new challenges.
JOINING THE CARBON CLUB
India's carbon market will soon be a reality, but will it fulfil its aim of reducing emissions? A report by PARTH KUMAR and MANAS AGRAWAL
Turn a new leaf
Scientists join hands to predict climate future of India's tropical forests
Festering troubles
The Democratic Republic of Congo struggles to contain mpox amid vaccine delays, conflict and fragile healthcare.
India sees unusual monsoon patterns
THE 2024 southwest monsoon has, between June 1 and September 1, led to excess rainfall in western and southern states such as Gujarat, Maharashtra and Tamil Nadu, while others like Nagaland, Manipur and Punjab recorded a deficit.